IL278010A - נוגדנים לגלקטין 10 - Google Patents
נוגדנים לגלקטין 10Info
- Publication number
- IL278010A IL278010A IL278010A IL27801020A IL278010A IL 278010 A IL278010 A IL 278010A IL 278010 A IL278010 A IL 278010A IL 27801020 A IL27801020 A IL 27801020A IL 278010 A IL278010 A IL 278010A
- Authority
- IL
- Israel
- Prior art keywords
- galectin
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4724—Lectins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1806099.6A GB201806099D0 (en) | 2018-04-13 | 2018-04-13 | Galectin-10 Antibodies |
GBGB1901648.4A GB201901648D0 (en) | 2019-02-06 | 2019-02-06 | Galectin-10 antibodies |
PCT/EP2019/059570 WO2019197675A1 (en) | 2018-04-13 | 2019-04-12 | Galectin-10 antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
IL278010A true IL278010A (he) | 2020-11-30 |
Family
ID=66240109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL278010A IL278010A (he) | 2018-04-13 | 2020-10-13 | נוגדנים לגלקטין 10 |
Country Status (12)
Country | Link |
---|---|
US (3) | US11066473B2 (he) |
EP (1) | EP3774905A1 (he) |
JP (1) | JP2021520825A (he) |
KR (1) | KR20210005070A (he) |
CN (1) | CN112166126A (he) |
AU (1) | AU2019250689A1 (he) |
BR (1) | BR112020020868A2 (he) |
CA (1) | CA3094215A1 (he) |
IL (1) | IL278010A (he) |
MX (1) | MX2020010821A (he) |
SG (1) | SG11202009140SA (he) |
WO (1) | WO2019197675A1 (he) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2019250689A1 (en) | 2018-04-13 | 2020-10-08 | Universiteit Gent | Galectin-10 antibodies |
US11860114B2 (en) * | 2020-03-26 | 2024-01-02 | David Hurwitz | Determining atomic coordinates from X-ray diffraction data |
WO2021223079A1 (zh) * | 2020-05-06 | 2021-11-11 | 科稷达隆(北京)生物技术有限公司 | 一种纳米抗体及其应用 |
CN113667000B (zh) * | 2021-08-31 | 2022-08-19 | 中国医学科学院基础医学研究所 | 多肽在制备治疗2型免疫疾病的药物中的应用 |
CN113666999B (zh) * | 2021-08-31 | 2022-08-19 | 中国医学科学院基础医学研究所 | 用于治疗2型免疫疾病的多肽 |
CN113999287B (zh) * | 2021-12-02 | 2023-06-27 | 深圳湾实验室坪山生物医药研发转化中心 | 一种靶向半乳糖凝集素-10的多肽抑制剂及其制备方法和用途 |
CN118488967A (zh) | 2022-01-18 | 2024-08-13 | 阿根思有限公司 | 半乳凝素-10抗体 |
CN118434440A (zh) | 2022-01-18 | 2024-08-02 | 阿根思有限公司 | Fab片段的雾化 |
WO2023150260A2 (en) * | 2022-02-03 | 2023-08-10 | Regents Of The University Of Minnesota | Compounds that target tem8, compositions, and methods |
WO2023153496A1 (ja) * | 2022-02-10 | 2023-08-17 | 国立大学法人大阪大学 | 好酸球増多症又は気管支喘息バイオマーカー |
CN115785245A (zh) * | 2022-07-18 | 2023-03-14 | 上海博满生物科技有限公司 | 一种半乳糖凝集素10晶体及其制备的抗体IgY和药物制剂 |
CN115902204A (zh) * | 2022-09-23 | 2023-04-04 | 北京大学第三医院(北京大学第三临床医学院) | 一种外泌体形式半乳糖凝集素9的检测方法与试剂盒 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
DE10333406A1 (de) * | 2003-07-15 | 2005-02-10 | Protagen Ag | T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen |
GB2461546B (en) | 2008-07-02 | 2010-07-07 | Argen X Bv | Antigen binding polypeptides |
JP7236216B2 (ja) * | 2015-04-23 | 2023-03-09 | ナントミクス,エルエルシー | がんのネオエピトープ |
CN106645752B (zh) * | 2016-12-27 | 2018-02-16 | 中南大学湘雅医院 | Galectin‑10及其特异性抗体在制备检测鼻咽癌试剂盒中的应用 |
AU2019250689A1 (en) | 2018-04-13 | 2020-10-08 | Universiteit Gent | Galectin-10 antibodies |
-
2019
- 2019-04-12 AU AU2019250689A patent/AU2019250689A1/en not_active Abandoned
- 2019-04-12 JP JP2020556304A patent/JP2021520825A/ja active Pending
- 2019-04-12 MX MX2020010821A patent/MX2020010821A/es unknown
- 2019-04-12 KR KR1020207032847A patent/KR20210005070A/ko unknown
- 2019-04-12 CN CN201980035738.2A patent/CN112166126A/zh active Pending
- 2019-04-12 BR BR112020020868-0A patent/BR112020020868A2/pt active Search and Examination
- 2019-04-12 SG SG11202009140SA patent/SG11202009140SA/en unknown
- 2019-04-12 US US16/382,997 patent/US11066473B2/en active Active
- 2019-04-12 EP EP19718651.3A patent/EP3774905A1/en active Pending
- 2019-04-12 CA CA3094215A patent/CA3094215A1/en active Pending
- 2019-04-12 WO PCT/EP2019/059570 patent/WO2019197675A1/en unknown
-
2020
- 2020-10-13 IL IL278010A patent/IL278010A/he unknown
-
2021
- 2021-03-08 US US17/194,950 patent/US11713354B2/en active Active
-
2023
- 2023-06-07 US US18/330,943 patent/US20240026010A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20240026010A1 (en) | 2024-01-25 |
WO2019197675A1 (en) | 2019-10-17 |
KR20210005070A (ko) | 2021-01-13 |
SG11202009140SA (en) | 2020-10-29 |
US20190367619A1 (en) | 2019-12-05 |
CN112166126A (zh) | 2021-01-01 |
JP2021520825A (ja) | 2021-08-26 |
US20210332140A1 (en) | 2021-10-28 |
EP3774905A1 (en) | 2021-02-17 |
CA3094215A1 (en) | 2019-10-17 |
BR112020020868A2 (pt) | 2021-04-06 |
MX2020010821A (es) | 2021-01-15 |
US11713354B2 (en) | 2023-08-01 |
US11066473B2 (en) | 2021-07-20 |
AU2019250689A1 (en) | 2020-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279321A (he) | נוגדן נגד SIRPalpha | |
SG11202106214YA (en) | Novel anti-ccr8 antibody | |
IL280780A (he) | נוגדנים אנטי- tigit | |
IL280013A (he) | נוגדנים אנטי- il36r | |
IL279352A (he) | נוגדנים של il-11ra | |
GB201709808D0 (en) | Antibodies | |
IL278010A (he) | נוגדנים לגלקטין 10 | |
IL289112A (he) | נוגדנים נגד tigit | |
IL277030A (he) | נוגדנים | |
GB201707561D0 (en) | GARP-TGF-beta antibodies | |
IL291068A (he) | נוגדנים אנטי- cd73 | |
SG11202106171WA (en) | Anti-btla antibodies | |
ZA202101177B (en) | Anti-btla antibody | |
IL284584A (he) | נוגדנים אנטי-tigit | |
GB201811368D0 (en) | Antibody | |
IL281594A (he) | נוגדנים כנגד klrg1 | |
GB201905150D0 (en) | Ant-ige antibodies | |
GB201817172D0 (en) | Antibody | |
GB201806084D0 (en) | Antibodies | |
GB201917480D0 (en) | Antibodies | |
GB201900732D0 (en) | Antibodies | |
IL289160A (he) | נוגדנים אנטי- angpt2 | |
GB201711785D0 (en) | Antibodies | |
SG11202105718TA (en) | Modified antibodies | |
GB201819952D0 (en) | Antibodies |